Pulmonary Medicine
- New AstraZeneca data presented at ATS 2023 strengthen the body of evidence supporting early intervention with Breztri in COPD
- ECO MEDICS-ECO PHYSICS, INC. to Exhibit at ATS 2023 International Conference
- Hyfe Al Announces Plans to Launch Digital Therapeutic to Provide End to End Care to Cough Suffers
- Illuminate Announces Pioneering Clinical Surveillance Capabilities that Unify and Streamline Lung Nodule Patient Management
- Kinaset Therapeutics to Present at the American Thoracic Society (ATS) 2023 Respiratory Innovation Summit
- Polarean-First clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical Center
- Pulmonary Fibrosis Foundation - Investigators Use Pulmonary Fibrosis Foundation Care Center Network and Patient Registry to Study Improved Outcomes for Patients with Interstitial Lung Disease
- Thirona - Artificial Intelligence Could Enable Life-Saving Early Diagnosis and Advance the Treatment of Pulmonary Hypertension
- Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023
- Vitalograph Reveals their Most Powerful, Versatile and Connected Handheld Spirometer Ever
- Zambon Completes Enrollment in Phase 3 Clinical Development Program Evaluating Liposomal Cyclosporine A for Inhalation (L-CsA-i) in Patients with Bronchiolitis Obliterans Syndrome (BOS)
Critical Care
- Immune IQ - American Thoracic Society Selects Immune IQ to Present Breakthrough Point-of-Care Diagnostic Technology at the 2023 Respiratory Innovation Summit
- Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023
